Biophysical Comparability of the Same Protein From Different Manufacturers: A Case Study Using Epoetin Alfa From Epogen® and Eprex®
- 1 September 2006
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 95 (9), 1931-1943
- https://doi.org/10.1002/jps.20649
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Characterizing biological products and assessing comparability following manufacturing changesNature Biotechnology, 2004
- Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here?Nephrology Dialysis Transplantation, 2004
- Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than anotherCurrent Medical Research and Opinion, 2004
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNew England Journal of Medicine, 2002
- Simplified proteins: minimalist solutions to the ‘protein folding problem’Current Opinion in Structural Biology, 1998
- Thermodynamic Analysis of Human Plasma Apolipoprotein C-1: High-Temperature Unfolding and Low-Temperature Oligomer DissociationBiochemistry, 1998
- Time-resolved biophysical methods in the study of protein foldingCurrent Opinion in Structural Biology, 1996
- Epoetin AlfaDrugs, 1995
- Principles that Govern the Folding of Protein ChainsScience, 1973
- Computed circular dichroism spectra for the evaluation of protein conformationBiochemistry, 1969